Glucagon-like peptide-1 (GLP-1) receptor agonists are injectable medications primarily prescribed for type 2 diabetes management and, in some formulations, for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Most of these side effects improve after the first few times you take the medication
For tirzepatide specifically, the semaglutide dosage calculator provides a useful reference point for understanding GLP-1 agonist dosing principles, while the syringe dosage guide covers the mechanics of drawing accurate doses
There are times we may need to approve a drug before we cover it
GLP-1 receptor agonists GLP-1 receptor monoagonists According to their pharmacodynamics and pharmacokinetic properties, the GLP-1RAs are categorized as either short-acting or long-acting agents
W., Sattar, N., Aizenberg, D., Mao, H., Zhang, S., Ahmad, N